ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,236,000
-57.9%
5,700
-77.7%
0.00%
-71.4%
Q3 2019$2,937,000
-44.2%
25,530
-18.2%
0.01%
-41.7%
Q1 2019$5,259,000
+179.7%
31,195
+61.6%
0.01%
+140.0%
Q4 2018$1,880,000
-10.2%
19,300
+28.7%
0.01%0.0%
Q2 2018$2,093,00015,0000.01%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders